About ClearBatch

ClearBatch publishes plain-English research profiles for peptides. Each profile is built from primary literature and public regulatory records, and is structured so a reader can see, at a glance, how strong the evidence behind every claim actually is. ClearBatch also maintains a trust-verification directory of the laboratories that test peptide products.

Alongside the research hub, ClearBatch operates a wholesale sourcing arm that supplies vetted, independently third-party-tested research peptides and reagents to research labs, pharmacies, and other B2B buyers. See wholesale sourcing for how it works.

Every peptide profile covers:

• Evidence-tiered claims, every benefit a peptide is associated with, rated against the strength of the evidence behind it
• Mechanism of action, the biological pathways involved, with the caveats that apply
• Research timeline and key studies, each study presented with an honest-read summary of its limitations
• Regulatory status, where the peptide stands in the USA, Canada, UK, EU, Australia, and under WADA
• Safety profile, reported side effects, theoretical concerns, contraindications, and interactions

Every claim on a peptide page carries one of five evidence tiers. The tier reflects the strongest evidence available for that specific claim, not the peptide's general reputation.

Every factual claim on a peptide profile is traceable to a specific primary source: a PubMed-indexed study, a clinical trial record, a regulatory filing, or an equivalent public document. Claims rated Strong Human, Preliminary Human, or Animal Only must carry at least one citation.

ClearBatch never fabricates sources to satisfy a claim. If the honest answer is that no study supports a claim, the profile says so and rates the claim accordingly. Key studies are presented with an honest-read summary that states the limitations, conflicts of interest, and gaps a casual reading would miss.

Regulatory status is recorded separately for each jurisdiction ClearBatch tracks: the USA, Canada, the UK, the EU, Australia, and the WADA prohibited list. Each entry carries the date it was last verified against the relevant registry.

Status in one jurisdiction does not imply status in another. A peptide can be an approved medicine in one country, a research chemical in another, and prohibited in sport everywhere. The per-jurisdiction table on each profile is the authoritative framing; it should not be generalized across rows.

ClearBatch maintains a directory of the laboratories that test peptide products. Each lab is assessed against eight independent verification signals: business registration, CLIA certification, ISO 17025 accreditation, physical address, professional staff, public verification portal, cross-validation against other labs, and web presence. Those signals combine into a trust tier from 1 to 5.

• ClearBatch content is not medical advice, and nothing on the site is a recommendation to use any peptide
• Peptides profiled here are, in most jurisdictions, not approved for human consumption; the Regulatory Status table on each page is the authoritative reference
• An evidence tier rates the strength of published evidence. It is not a safety rating and not an endorsement